Skip to main content
Erschienen in: Surgical Endoscopy 12/2016

12.04.2016

Combining endoscopic submucosal dissection and endoscopic mucosal resection to treat neoplasia in Barrett’s esophagus

verfasst von: Ian Holmes, Tressia Hing, Shai Friedland

Erschienen in: Surgical Endoscopy | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Piecemeal endoscopic mucosal resection (EMR) is the standard treatment of nodular Barrett’s esophagus dysplasia and T1a cancer. Piecemeal resection may be incomplete and makes precise histologic assessment difficult. Endoscopic submucosal dissection (ESD) is a technique that enables en-bloc resection but has not gained widespread acceptance due to its technical difficulty, risk and long procedure time.

Methods

We developed a protocol consisting of a combination of a limited ESD with supplementary EMR in the same session if necessary, designed to increase en-bloc resection of the most worrisome neoplastic area while maximizing the rate of complete resection of dysplasia. Records of consecutive patients referred for treatment during a 2-year period were reviewed.

Results

Eleven patients were treated: two with ESD and nine with combined ESD/EMR. Eight patients had mucosal lesions; three patients had submucosally invasive cancer and were referred to surgery. Five of the 8 mucosal lesions were removed en-bloc by ESD with dysplasia-free margins. Two patients with T1a cancer had low-grade dysplasia in the ESD margins and removal of all dysplasia on EMR. One patient with T1a cancer had high-grade dysplasia in the ESD margins and on EMR. He required a second endoscopy to remove residual neoplasia. There were no adverse events. The mean procedure time was 66.4 ± 15.1 min.

Conclusions

Combining a limited ESD with EMR in the same session enables efficient treatment of visible dysplastic lesions in Barrett’s esophagus.
Literatur
1.
Zurück zum Zitat Kothari S, Kaul V (2015) Endoscopic mucosal resection and endoscopic submucosal dissection for endoscopic therapy of Barrett’s Esophagus-related neoplasia. Gastroenterol Clin North Am 44:317–335CrossRefPubMed Kothari S, Kaul V (2015) Endoscopic mucosal resection and endoscopic submucosal dissection for endoscopic therapy of Barrett’s Esophagus-related neoplasia. Gastroenterol Clin North Am 44:317–335CrossRefPubMed
2.
Zurück zum Zitat Gaddam S, Wani S (2013) Endoscopic therapy of barrett esophagus. Gastrointest Endosc Clin N Am 23:1–16CrossRefPubMed Gaddam S, Wani S (2013) Endoscopic therapy of barrett esophagus. Gastrointest Endosc Clin N Am 23:1–16CrossRefPubMed
3.
Zurück zum Zitat Pouw RE, van Vilsteren FG, Peters FP, Alvarez Herrero L, Ten Kate FJ et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRefPubMed Pouw RE, van Vilsteren FG, Peters FP, Alvarez Herrero L, Ten Kate FJ et al (2011) Randomized trial on endoscopic resection-cap versus multiband mucosectomy for piecemeal endoscopic resection of early Barrett’s neoplasia. Gastrointest Endosc 74:35–43CrossRefPubMed
4.
Zurück zum Zitat Berry M (2014) Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 6(Suppl 3):S289–S297PubMedPubMedCentral Berry M (2014) Esophageal cancer: staging system and guidelines for staging and treatment. J Thorac Dis. 6(Suppl 3):S289–S297PubMedPubMedCentral
5.
Zurück zum Zitat Oka S, Tanaka S, Saito Y, Iishi H, Kudo SE et al (2015) Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 110:697–707CrossRefPubMed Oka S, Tanaka S, Saito Y, Iishi H, Kudo SE et al (2015) Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Am J Gastroenterol 110:697–707CrossRefPubMed
7.
Zurück zum Zitat Uedo N, Takeuchi Y, Ishihara R (2012) Endoscopic management of early gastric cancer: endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese high-volume center and literature review. Ann Gastroenterol 25:281–290PubMedPubMedCentral Uedo N, Takeuchi Y, Ishihara R (2012) Endoscopic management of early gastric cancer: endoscopic mucosal resection or endoscopic submucosal dissection: data from a Japanese high-volume center and literature review. Ann Gastroenterol 25:281–290PubMedPubMedCentral
8.
Zurück zum Zitat Oyama T (2014) Esophageal ESD: technique and prevention of complications. Gastrointest Endosc Clin N Am 24:201–212CrossRefPubMed Oyama T (2014) Esophageal ESD: technique and prevention of complications. Gastrointest Endosc Clin N Am 24:201–212CrossRefPubMed
9.
Zurück zum Zitat Higuchi K, Tanabe S, Azuma M, Katada C, Sasaki T et al (2013) A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc 78:704–710CrossRefPubMed Higuchi K, Tanabe S, Azuma M, Katada C, Sasaki T et al (2013) A phase II study of endoscopic submucosal dissection for superficial esophageal neoplasms (KDOG 0901). Gastrointest Endosc 78:704–710CrossRefPubMed
10.
Zurück zum Zitat Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B (2012) Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus. Endoscopy 44:1105–1113CrossRefPubMed Neuhaus H, Terheggen G, Rutz EM, Vieth M, Schumacher B (2012) Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett’s esophagus. Endoscopy 44:1105–1113CrossRefPubMed
11.
Zurück zum Zitat Hoteya S, Matsui A, Iizuka T, Kikuchi D, Yamada A et al (2013) Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion 87:29–33CrossRefPubMed Hoteya S, Matsui A, Iizuka T, Kikuchi D, Yamada A et al (2013) Comparison of the clinicopathological characteristics and results of endoscopic submucosal dissection for esophagogastric junction and non-junctional cancers. Digestion 87:29–33CrossRefPubMed
12.
Zurück zum Zitat Probst A, Aust D, Märkl B, Anthuber M, Messmann H (2015) Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 47:113–121PubMed Probst A, Aust D, Märkl B, Anthuber M, Messmann H (2015) Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 47:113–121PubMed
13.
Zurück zum Zitat Chevaux JB, Piessevaux H, Jouret-Mourin A, Yeung R, Danse E, Deprez PH (2015) Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett’s neoplasia. Endoscopy 47:103–112CrossRefPubMed Chevaux JB, Piessevaux H, Jouret-Mourin A, Yeung R, Danse E, Deprez PH (2015) Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett’s neoplasia. Endoscopy 47:103–112CrossRefPubMed
14.
Zurück zum Zitat Falk GW (2015) Endoscopic submucosal dissection for Barrett-associated neoplasia: is it ready for the endoscopist’s toolbox? Endoscopy 47:97–98CrossRefPubMed Falk GW (2015) Endoscopic submucosal dissection for Barrett-associated neoplasia: is it ready for the endoscopist’s toolbox? Endoscopy 47:97–98CrossRefPubMed
15.
Zurück zum Zitat Toyonaga T, Man-I M, Morita Y, Azuma T (2014) Endoscopic submucosal dissection (ESD) versus simplified/hybrid ESD. Gastrointest Endosc Clin N Am 24:191–199CrossRefPubMed Toyonaga T, Man-I M, Morita Y, Azuma T (2014) Endoscopic submucosal dissection (ESD) versus simplified/hybrid ESD. Gastrointest Endosc Clin N Am 24:191–199CrossRefPubMed
16.
Zurück zum Zitat Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L (2006) T he development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399CrossRefPubMed Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L (2006) T he development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria. Gastroenterology 131:1392–1399CrossRefPubMed
17.
Zurück zum Zitat Bae JH, Yang DH, Lee S, Soh JS, Lee S (2015) Optimized hybrid endoscopic submucosal dissection for colorectal tumors: a randomized controlled trial. Gastrointest Endosc, in press Bae JH, Yang DH, Lee S, Soh JS, Lee S (2015) Optimized hybrid endoscopic submucosal dissection for colorectal tumors: a randomized controlled trial. Gastrointest Endosc, in press
18.
Zurück zum Zitat Young PE, Gentry AB, Acosta RD, Greenwald BD, Riddle M (2010) Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 8:1037–1041CrossRefPubMed Young PE, Gentry AB, Acosta RD, Greenwald BD, Riddle M (2010) Endoscopic ultrasound does not accurately stage early adenocarcinoma or high-grade dysplasia of the esophagus. Clin Gastroenterol Hepatol 8:1037–1041CrossRefPubMed
19.
Zurück zum Zitat Muthusamy VR, Kim S, Wallace MB (2015) Advanced imaging in Barrett’s esophagus. Gastroenterol Clin N Am 44:439–458CrossRef Muthusamy VR, Kim S, Wallace MB (2015) Advanced imaging in Barrett’s esophagus. Gastroenterol Clin N Am 44:439–458CrossRef
20.
Zurück zum Zitat Bahin F, Jayanna M, Williams SJ, Lee EY, Bourke MJ (2015) Efficacy of viscous budesonide slurry for prevention of esophageal stricture formation after complete endoscopic mucosal resection of short-segment Barrett’s neoplasia. Endoscopy, in press Bahin F, Jayanna M, Williams SJ, Lee EY, Bourke MJ (2015) Efficacy of viscous budesonide slurry for prevention of esophageal stricture formation after complete endoscopic mucosal resection of short-segment Barrett’s neoplasia. Endoscopy, in press
21.
Zurück zum Zitat Pech O, May A, Manner H, Behrens A, Pohl J (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660CrossRefPubMed Pech O, May A, Manner H, Behrens A, Pohl J (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146:652–660CrossRefPubMed
Metadaten
Titel
Combining endoscopic submucosal dissection and endoscopic mucosal resection to treat neoplasia in Barrett’s esophagus
verfasst von
Ian Holmes
Tressia Hing
Shai Friedland
Publikationsdatum
12.04.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2016
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4885-y

Weitere Artikel der Ausgabe 12/2016

Surgical Endoscopy 12/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.